Cargando…

Nutraceuticals in Brown Adipose Tissue Activation

Obesity and its associated comorbidities have become pandemic, and challenge the global healthcare system. Lifestyle changes, nutritional interventions and phamaceuticals should be differently combined in a personalized strategy to tackle such a public health burden. Altered brown adipose tissue (BA...

Descripción completa

Detalles Bibliográficos
Autores principales: Armani, Andrea, Feraco, Alessandra, Camajani, Elisabetta, Gorini, Stefania, Lombardo, Mauro, Caprio, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776638/
https://www.ncbi.nlm.nih.gov/pubmed/36552762
http://dx.doi.org/10.3390/cells11243996
_version_ 1784855913940647936
author Armani, Andrea
Feraco, Alessandra
Camajani, Elisabetta
Gorini, Stefania
Lombardo, Mauro
Caprio, Massimiliano
author_facet Armani, Andrea
Feraco, Alessandra
Camajani, Elisabetta
Gorini, Stefania
Lombardo, Mauro
Caprio, Massimiliano
author_sort Armani, Andrea
collection PubMed
description Obesity and its associated comorbidities have become pandemic, and challenge the global healthcare system. Lifestyle changes, nutritional interventions and phamaceuticals should be differently combined in a personalized strategy to tackle such a public health burden. Altered brown adipose tissue (BAT) function contributes to the pathophysiology of obesity and glucose metabolism dysfunctions. BAT thermogenic activity burns glucose and fatty acids to produce heat through uncoupled respiration, and can dissipate the excessive calorie intake, reduce glycemia and circulate fatty acids released from white adipose tissue. Thus, BAT activity is expected to contribute to whole body energy homeostasis and protect against obesity, diabetes and alterations in lipid profile. To date, pharmacological therapies aimed at activating brown fat have failed in clinical trials, due to cardiovascular side effects or scarce efficacy. On the other hand, several studies have identified plant-derived chemical compounds capable of stimulating BAT thermogenesis in animal models, suggesting the translational applications of dietary supplements to fight adipose tissue dysfunctions. This review describes several nutraceuticals with thermogenic properties and provides indications, at a molecular level, of the regulation of the adipocyte thermogenesis by the mentioned phytochemicals.
format Online
Article
Text
id pubmed-9776638
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97766382022-12-23 Nutraceuticals in Brown Adipose Tissue Activation Armani, Andrea Feraco, Alessandra Camajani, Elisabetta Gorini, Stefania Lombardo, Mauro Caprio, Massimiliano Cells Review Obesity and its associated comorbidities have become pandemic, and challenge the global healthcare system. Lifestyle changes, nutritional interventions and phamaceuticals should be differently combined in a personalized strategy to tackle such a public health burden. Altered brown adipose tissue (BAT) function contributes to the pathophysiology of obesity and glucose metabolism dysfunctions. BAT thermogenic activity burns glucose and fatty acids to produce heat through uncoupled respiration, and can dissipate the excessive calorie intake, reduce glycemia and circulate fatty acids released from white adipose tissue. Thus, BAT activity is expected to contribute to whole body energy homeostasis and protect against obesity, diabetes and alterations in lipid profile. To date, pharmacological therapies aimed at activating brown fat have failed in clinical trials, due to cardiovascular side effects or scarce efficacy. On the other hand, several studies have identified plant-derived chemical compounds capable of stimulating BAT thermogenesis in animal models, suggesting the translational applications of dietary supplements to fight adipose tissue dysfunctions. This review describes several nutraceuticals with thermogenic properties and provides indications, at a molecular level, of the regulation of the adipocyte thermogenesis by the mentioned phytochemicals. MDPI 2022-12-10 /pmc/articles/PMC9776638/ /pubmed/36552762 http://dx.doi.org/10.3390/cells11243996 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Armani, Andrea
Feraco, Alessandra
Camajani, Elisabetta
Gorini, Stefania
Lombardo, Mauro
Caprio, Massimiliano
Nutraceuticals in Brown Adipose Tissue Activation
title Nutraceuticals in Brown Adipose Tissue Activation
title_full Nutraceuticals in Brown Adipose Tissue Activation
title_fullStr Nutraceuticals in Brown Adipose Tissue Activation
title_full_unstemmed Nutraceuticals in Brown Adipose Tissue Activation
title_short Nutraceuticals in Brown Adipose Tissue Activation
title_sort nutraceuticals in brown adipose tissue activation
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776638/
https://www.ncbi.nlm.nih.gov/pubmed/36552762
http://dx.doi.org/10.3390/cells11243996
work_keys_str_mv AT armaniandrea nutraceuticalsinbrownadiposetissueactivation
AT feracoalessandra nutraceuticalsinbrownadiposetissueactivation
AT camajanielisabetta nutraceuticalsinbrownadiposetissueactivation
AT gorinistefania nutraceuticalsinbrownadiposetissueactivation
AT lombardomauro nutraceuticalsinbrownadiposetissueactivation
AT capriomassimiliano nutraceuticalsinbrownadiposetissueactivation